The Indian companies Cipla and Serum Institute have joined hands to provide affordable pediatric vaccines in Europe.
Cipla-Serum ally for Europe vaccine push
The Indian companies Cipla and Serum Institute have joined hands to provide affordable pediatric vaccines in Europe.
More from Anti-infective
More from Therapy Areas
• By
The Oxford group has linked up with the NHS Cancer Vaccine Launch Pad.
• By
Bristol Myers Squibb notched two approvals in one week for its immuno-oncology combination, pitting the regimen head-to-head with Keytruda in a subset of CRC and with two combos in HCC.
• By
The company presented positive Phase III data from a subset analysis of ICONIC-LEAD comprising patients with moderate-to-severe plaque psoriasis.